临床神经外科杂志
臨床神經外科雜誌
림상신경외과잡지
JOURNAL OF CLINICAL NEUROSURGERY
2014年
6期
462-464
,共3页
祝海平%孔刚%陈进%朱业余%程恺远%徐宏%殷昊
祝海平%孔剛%陳進%硃業餘%程愷遠%徐宏%慇昊
축해평%공강%진진%주업여%정개원%서굉%은호
侧裂-岛叶入路%颅内压监测%基底节区脑出血
側裂-島葉入路%顱內壓鑑測%基底節區腦齣血
측렬-도협입로%로내압감측%기저절구뇌출혈
transsylvian-transinsular approach%intracranial pressure monitoring%basal ganglia hemorrhage
目的:探讨颅内压( ICP)监测在小骨窗经侧裂-岛叶入路清除基底节区脑出血术后的作用。方法回顾性分析60例基底节区脑出血的患者的临床资料和ICP监测数据,根据术后是否行ICP监测分为ICP监测组(n=36)和对照组(n=24),比较两组患者的术后人均甘露醇使用量,再出血率,平均住院时间,术后死亡率以及远期疗效等相关指标差异。结果术后2 h复查头颅CT,54例血肿清除量大于80%,术后再出血13例,ICP监测组7例,对照组6例,均行二次手术。 ICP的高峰期出现在术后的3~7 d内。结论脑出血术后ICP监测能及时反映病情变化、调整治疗方案、利于患者恢复。
目的:探討顱內壓( ICP)鑑測在小骨窗經側裂-島葉入路清除基底節區腦齣血術後的作用。方法迴顧性分析60例基底節區腦齣血的患者的臨床資料和ICP鑑測數據,根據術後是否行ICP鑑測分為ICP鑑測組(n=36)和對照組(n=24),比較兩組患者的術後人均甘露醇使用量,再齣血率,平均住院時間,術後死亡率以及遠期療效等相關指標差異。結果術後2 h複查頭顱CT,54例血腫清除量大于80%,術後再齣血13例,ICP鑑測組7例,對照組6例,均行二次手術。 ICP的高峰期齣現在術後的3~7 d內。結論腦齣血術後ICP鑑測能及時反映病情變化、調整治療方案、利于患者恢複。
목적:탐토로내압( ICP)감측재소골창경측렬-도협입로청제기저절구뇌출혈술후적작용。방법회고성분석60례기저절구뇌출혈적환자적림상자료화ICP감측수거,근거술후시부행ICP감측분위ICP감측조(n=36)화대조조(n=24),비교량조환자적술후인균감로순사용량,재출혈솔,평균주원시간,술후사망솔이급원기료효등상관지표차이。결과술후2 h복사두로CT,54례혈종청제량대우80%,술후재출혈13례,ICP감측조7례,대조조6례,균행이차수술。 ICP적고봉기출현재술후적3~7 d내。결론뇌출혈술후ICP감측능급시반영병정변화、조정치료방안、리우환자회복。
Objective To observe the change regularity of intracranial pressure( ICP) and investigate the guiding significance of the application of ICP monitoring in basal ganglia hemorrhage.Methods The clinical data and ICP monitoring data of 60 patients with basal ganglia hemorrhage were analyzed retrospectively.All the patients were divided into ICP monitoring group (n=36) and control group (n=24) .The dosage of mannitol postoperatively, the rate of rebleeding, the length of hospitalization, mortality and long-term outcomes were compared between two groups. Results Hematomas were evacuated satisfactorily in all patients based on postoperative CT examination two hours later.The rate of hematomas evacuateing exceeding 80%extended 54 patients, the rebleeding patients were 7 in ICP monitoring group and 6 in control group.Conclusion The combination of ICP monitoring being equipped with the timely observation of illness changes, regulation of therapeutic regimens and rapid recovery for these patients.